Search Results

Defymed: Towards a Physiological Treatment for Type 1 Diabetes

A new fund raising round for Defymed, to allow the entry into clinical phase of its ExOlin® device

May 5, 2020

·

4 min read

Defymed receives approval to start its pilot clinical study with ExOlin®: the promise of a physiological treatment for diabetic patients

The French authorities validate the start of the therapeutic trial to evaluate the safety of the ExOlin® device for patients suffering from poorly controlled type 1 diabetes with severe glycaemic fluctuations and prone to severe hypoglycaemia.

January 25, 2022

·

5 min read

Defymed Accelerates Its Development in the United States: One Step Closer to Patients

Medical technology company Defymed, specialized in the design and development of innovative medical devices for the delivery of therapeutic treatments, will be exploring business and scientific opportunities in Boston this September 25 to October 5 as part of the Innouvo program.

September 20, 2019

·

5 min read

Innovative Medical Devices for the Treatment of Diabetes, Defymed Strengthens Its Position as a Worldwide Leader

As part of this approach, two innovative medical devices, ExOlin® and MailPan®, have been developed by Defymed to provide patients with a more physiological treatment.

February 12, 2018

·

2 min read

Defymed Is Developing Exolin, A New Insulin Delivery Device

July 10, 2017

·

3 min read

Business

Defymed Enters Partnership With Semma Therapeutics

December 12, 2016

·

3 min read

Policy

Kadimastem and Defymed Awarded Grant in the EU’s Prestigious Eurostars Program for the Clinical Development of an Integrated Product for the Treatment of Diabetes

The projected project budget is NIS 5.4 million for two years, with Kadimastem’s share for the first year being NIS 1.5 million. The participation of the Innovation Authority will be at the rate of 50% of the Kadimastem budget

November 12, 2018

·

4 min read

Business

Defymed Receives Support From JDRF To Fight Type 1 Diabetes

July 12, 2016

·

5 min read

Live Cell Encapsulation Market Size - Quantitative Research By QYResearch Medical

The global live cell encapsulation market size was USD 269 million in 2020 and is expected to register a CAGR of 3.6% during the forecast period

November 14, 2022

·

8 min read

Artificial Pancreas Device System Market Increasing Medical Tourism in Emerging Nations

According to The Insight Partners market research study titled ‘Artificial Pancreas Device Systems Market to 2025 - Global Analysis and Forecasts by Type and Geography.

June 9, 2021

·

5 min read